🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 21 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/05/2005 | 23,81 | 23,81 | 21,34 | 22,01 | -8,41% | 10,38% | 586.805 |
| 19/05/2005 | 23,69 | 24,10 | 23,21 | 24,03 | +1,90% | 3,79% | 224.286 |
| 18/05/2005 | 23,58 | 24,22 | 23,09 | 23,58 | +0,32% | 4,76% | 221.134 |
| 17/05/2005 | 24,14 | 24,29 | 23,13 | 23,51 | -0,32% | 4,81% | 205.478 |
| 16/05/2005 | 22,87 | 23,58 | 22,27 | 23,58 | +4,30% | 5,73% | 132.675 |
| 13/05/2005 | 23,02 | 23,24 | 22,12 | 22,61 | -1,95% | 4,88% | 293.429 |
| 12/05/2005 | 22,20 | 23,36 | 22,08 | 23,06 | +3,70% | 5,73% | 268.342 |
| 11/05/2005 | 21,56 | 22,27 | 20,77 | 22,23 | +3,66% | 6,94% | 332.008 |
| 10/05/2005 | 20,77 | 21,97 | 20,44 | 21,45 | +2,32% | 7,39% | 605.293 |
| 09/05/2005 | 20,96 | 21,22 | 20,29 | 20,96 | -0,18% | 4,46% | 169.330 |
| 06/05/2005 | 21,34 | 21,41 | 20,77 | 21,00 | -1,23% | 2,98% | 176.009 |
| 05/05/2005 | 20,74 | 21,26 | 20,21 | 21,26 | +2,53% | 5,05% | 190.062 |
| 04/05/2005 | 20,29 | 20,85 | 20,10 | 20,74 | +1,84% | 3,69% | 173.017 |
| 03/05/2005 | 20,21 | 20,47 | 19,84 | 20,36 | +1,49% | 3,15% | 333.371 |
| 02/05/2005 | 19,58 | 20,21 | 19,24 | 20,06 | +1,52% | 4,97% | 274.647 |
| 29/04/2005 | 20,47 | 20,59 | 19,58 | 19,76 | -3,47% | 4,94% | 250.335 |
| 28/04/2005 | 20,62 | 20,89 | 20,32 | 20,47 | -2,32% | 2,72% | 258.163 |
| 27/04/2005 | 20,55 | 21,52 | 20,36 | 20,96 | +1,82% | 5,65% | 203.902 |
| 26/04/2005 | 20,32 | 20,89 | 19,88 | 20,59 | +0,73% | 4,97% | 200.188 |
| 25/04/2005 | 19,46 | 20,77 | 19,46 | 20,44 | +4,60% | 6,73% | 246.087 |
| 22/04/2005 | 19,16 | 20,17 | 18,94 | 19,54 | +0,77% | 6,45% | 293.349 |
| 21/04/2005 | 17,97 | 19,84 | 17,78 | 19,39 | +9,05% | 11,46% | 590.706 |
| 20/04/2005 | 18,27 | 18,71 | 17,78 | 17,78 | -3,06% | 5,12% | 103.126 |
| 19/04/2005 | 17,82 | 18,57 | 17,82 | 18,34 | +2,94% | 4,20% | 151.457 |
| 18/04/2005 | 18,60 | 18,60 | 17,55 | 17,82 | -3,84% | 5,63% | 438.340 |
| 15/04/2005 | 18,75 | 19,05 | 18,00 | 18,53 | -1,79% | 5,59% | 389.556 |
| 14/04/2005 | 19,28 | 19,69 | 18,86 | 18,86 | -2,70% | 4,27% | 180.738 |
| 13/04/2005 | 20,55 | 20,55 | 19,28 | 19,39 | -5,65% | 6,19% | 191.371 |
| 12/04/2005 | 20,14 | 20,59 | 19,31 | 20,55 | +2,23% | 6,32% | 223.218 |
| 11/04/2005 | 20,06 | 20,70 | 19,95 | 20,10 | -0,74% | 3,73% | 224.847 |